Carregant...

In Vitro Anti-Helicobacter pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657

The new rifamycin derivatives KRM-1657 and KRM-1648 were evaluated for their in vitro antimicrobial activities against 44 strains of Helicobacter pylori. Although the drugs were not very active against other gram-negative bacteria, the MICs at which 90% of isolates are inhibited for these drugs were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Akada, Junko K., Shirai, Mutsunori, Fujii, Kenji, Okita, Kiwamu, Nakazawa, Teruko
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 1999
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC89113/
https://ncbi.nlm.nih.gov/pubmed/10223916
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!